pharma now has a lot of leverage in the price. if you can find a drug where there is nothing else on the market, where it can provide an actual benefit to patients, and with this drug it did improve life expectancy for people who had a very rare, terrible lung disorder that kills people typically within five years of diagnosis -- if you have those things, the sky is the limit on the price. there is even some drugs out there over $200,000 a year for patients, because there is nothing else, and the insurer of have their hands tied and pharma can charge whatever they want. >> this is a strategic play for roche, especially when it comes to the market for lung disorder drugs. >> we have an aging population and a population that has been more affected by tobacco, smoking, and pollution. for a disorder that is caused by genetic mutation, but what roche wants to do is increase its business in lung disorders because we have a population that is going to have more on cancer and asthma because of populations globally that are exposed to more

the four biotech horsemen of the big pharma apocalypse. stay with cramer!ver 20 million n kids everydayn our country lack access to healthy food. for the first time american kids are slated to live a shorter life span than their parents. it's a problem that we can turn around and change. revolution foods is a company we started to provide access to healthy, affordable, kid-inspired, chef-crafted food. we looked at what are the aspects of food that will help set up kids for success? making sure foods are made with high quality ingredients and prepared fresh everyday. our collaboration with citi has helped us really accelerate the expansion of our business in terms of how many communities we can serve. working with citi has also helped to fuel our innovation process and the speed at which we can bring new products into the grocery stores. we are employing 1,000 people across 27 urban areas and today, serve over 1 million meals a week. until every kid has built those life-long eating habits, we'll keep working. >>> i'd like to say there's always bull market so

big pharma needs a big incentive to spend that. and some health experts say that doesn't exist with ebola, a disease that breaks out sporadically. in fact, only when there's an outbreak does the real money start to rush in. check out this stock chart for tekmira pharmaceuticals, a vancouver-based company working on an ebola treatment. investors sent shares climbing earlier this week, but when cnn's dr. sanjay gupta broke the story that the serum give on the two americans infected with ebola was actually made by a different company, shares tanked. and it could be a roller coaster ride for those shares going forward now that the fda is getting closer to allowing experimental use of tekmira's drug. clearly investors are betting on which treatment will ultimately win fda approval. but in the meantime, people are dying. dr. sanjay gupta is cnn's chief medical correspondent. he has been all over this story really for months. sanjay, let's just get right to it. do the economics of drug development play a role here in why there is no ebola

shares of chugai pharma are rallying in japan. it is a 15.5%. the $10 billion deal will give them full control of chugai pharma. still to come, australia, home of sunny skies and sandy beaches and misery. the reason they are feeling down down under. nded months of unrest. more on that coming up. -- we saw .4%e growth they're in thailand for the economy. would be aght it picture of stalin gdp growth. stalling gdp growth. >> i was in bangkok to were three days ago. the expectation was for a shy decline in gdp for the end of the year and a recovery in the second half of the year starting to see that coming through. it wasn't really a massive impact of the coup had. brought a measure of stability that has perhaps improved some of the business environment. , in thecompanies said first half of the year, they did not see the slowdown. but it means that maybe the picture is a little bit more broad-based in terms of growth in thailand and not just bangkok. the index is up .4% since the coup. is it time to investor have we missed the boat? >> we are overw

we see this a lot in pharma.usiness development folks are always working on everything that crosses their desks. if something doesn't work out, you have another opportunity. roche has been very active in m&a. they are looking at small deals like this as darren o'day said in our interview. >> he was talking about wanting to do these types of acquisitions. might we see more deals like this? will they be of a similar nature? >> absolutely. roche has made clear they are not interested in the megamergers we have seen in the pharma industry this year with pfizer approaching astrazeneca. roche is happy with the business the way it has played out now. they have a big diagnostics business and a big pharma business. they are looking for projects and technologies they can add to those two. they are generating about $16 billion a year. we will see more deals from them. >> thank you very much. phil joining us from paris. now it is shaping up into a big week for telecoms. not only our earnings for vivendi out on thursday, but

big pharma needs a big incentive to spend that.ome health experts say that doesn't exist with ebola, a disease that breaks out sporadically. in fact, only when there's an outbreak does the real money start t

plus, i have a dublin based pharma player you never heard of until tonight. take notice.tick with cramer. >> announcer: don't miss a second of "mad money." follow @jimcramer on twitter. have a question? tweet cramer, #madtweets. send jim an e-mail to madmoney@cnbc.com or give us a call at 1-800-743-cnbc. miss something? head to madmoney.cnbc.com. are you sure we should take this billboard down? people find out state farm does car loans as well as they do insurance, our bank is through. good point. grab an edge. look there's two guys on the state farm borrow better banking sign. nope for real there's two dudes on the state farm borrow better banking sign. [ reporter ] breaking news from the state farm borrow better banking sign... we're seeing two men that have climbed the borrow better banking sign gentlemen please get down from the state farm borrow better banking sign. phil get the hose. okay he's getting the hose. alright, let's go. [ male announcer ] talk to a state farm agent about car loans that can save you hundreds. that's borrowing better. >>> has the bull market

the business model of the pharma companies is not hard to understand. it is the same one used by hollywood. they find interesting projects and they bring them in-house and then polish them, they get them through sensors, the fda, and their marketing and advertising teams start to work to deliver it to the public. it is long and risky and expensive, which is why, like drug companies choose to seek blockbusters. when you think about it targeted medicine, they are more like those little indie art films, not a big audience. if you are making a niche drug, the result is, it ends up being phenomenally expensive. it is hard to get the insurance companies to pay for it or for an individual to pay for it. the best medicines in depth helping the fewest people. kind of ironic. i started thinking about this a lot, how could this trend he reversed, how can we make a drug company that truly made faster, better, cheaper medicines and start to generate cancer drugs? you want to beat cancer, make better drugs. if i see everyone going one way, the whole industry is over

all right, chugai pharma.today. >> we are basically back to levels before this talk of the deal became public. we know now that roche is siding against bidding for the company. according to the management, chugai's management said, we don't like it. shares are back more or less. >> investors are saying, we don't like it either. david and john, thanks so much for that. that is the verdict on the stock exchange. thanks, and thank you for joining us. "on the move" coming up next. >> gr morning everybody. we are live in hong kong, you re watching "on the move." >> vast stretch of the global futures market is frozen. a technical glitch of the c.m.e. and dollar surging against its peers and not a citizen, not a problem. the politics of influence. and foreign exchanges with the

there are industries like food and pharma industries they need to buy growth. charles: pharma had this problem for a long time, drug companys in particular, even before tax inversion you could go overseas and get advantages, they have pipelines of blockbuster drugs spend a cazillion dollars on them, then they run out of way its make money. >> this is why the pfizer astrazeneca deal is the best deal that did not happen. second quarter was hot because the stock market was still eh . but as market goes up, i think that m&a world becomes frothy too. >> i'm ceo of xyz, i am sitting on a lot of cash but top line it grows down what do i do? >> it depends,y would say go -- i would say go out and buy something, i can't stan the buyback thing. charles: they use their company stock, instead of cash, that is the red flag, until then i think it goes on. almost time for our first investment idea. you know i love the semiconductors, one right now is ripe for a big move to the upside. stock is making a nice turn. this is a stock you want to be in if you want to make some money

kite pharma, of course, just went public in june. joining us from los angeles is the ceo dr. beldergren. thank you for joining us. >> thank you. >> it was a maude constitutionally, but 92% response rate. maybe you can put that in context for us. what does that bode for the prospects for this therapy? >> the second study that we have reported now on an extensive group of patient, with different blood cancers, and their response has been quite dramatic with over 90% of the patients responding to the treatment. it's interesting that these patients have received sever possible treatment, including chemotherapy and other new treatments that were available for them, and they have progressed. so these are the patients who are responding still with their own immune system to fight the cancer and in many cases beat tumors that were growing very rapidly completely disappeared and continue for the longest responses we have now, up to five years. >>> let's talk about the safety. i understand you did see some toxicities, some with fevers, low blood pressure, neurological features. maybe y

the whole process both faster and more efficient, and of course cheaper, which is why biotech and pharmanies are increasely outsourcing the work to charles river and others like it. rallied last year. we had faith it was on fire. then from the first week of april through the first week of may it dropped from 61 down to 50 and spent the next three months stuck in the low 50s, in part because of worries that drug companies were shifting resource budgets away from the early stage toward firms that specialize in later-stain trials. . crl off an 812 basis with higher than expected revenues. they did make an acquisition there. management raised the full-year guidance, so this stock with a 50% gain 20 months allege ready to resume the long march higher? let's take a look with the president and more about where it's headed. welcome back to "mad money." good to see you in person. jim, i have to admit, i'm kind of torn. on the one hand you say we are firing on multiple cylinders, seeing pretty much great growth, you talk about the idea this is it, sales growth exceeded 10%, but then you say, look,

pharma companye in focus. find out why. >♪ >> welcome to the stock exchange.taking ahead -- a look ahead to the opens in japan, south korea, and australia. >> good morning. i am looking at chugai pharmaceutical. there was some news that its biggest shareholder, roche, the biggest maker of cancer drugs, said to be in talks to buy the other 40% it doesn't already own. $10 billion perhaps the size of the deal. just this morning, chugai pharma said, nope, it's not happening, we are not having any talks. >> who reported it? >> it came out of bloomberg news, basically, based on our sources. but that was before the denial. there was a denial after. let's let the markets decide. >> i'm just covering myself. it's good stuff. >> let's dial things up. >> not quite as exciting as the top mover today. resonant is going to offer high-speed lte smartphone for about ¥2000 a month, $20 u.s. shares rose 1.5%, dramatically one of the better gainers. they will sell the phone online. that's an interesting one to follow, trying to compete in this very competitive, tightly-priced ma

an online textbook rental went public last year, and arena pharma. russell posted his worst four-week loss since september 2011. >>> sue, here's what we've got. shares of ver i sign, worked that berkshire hathaway has boosted its stake by 11% to about 10.5% of the overall company. this particular company has a market cap of around 7 billion. it gives secured domain names. those shares are up at session highs, but the stock is still down about 8% year to date, sue. >>> the dow negative for the year, the s&p only up about 4% assist last week 'sell-off. is it a good time to jump in we have hugh johnson and susan fulton joins us as well, she is president and founder of fbb capital partners. you both at this point say the market is not overvalued. that's a bit of a change for you, hugh. is it due to last week's sell-off? >> it really is. we were about 4%, sue, overvalued before we started last week. as i do the numbers, we got down to a level which i think is about a half of is% and 1% undervalued. it's the first time i've seen undervaluation in a long ti

. >> big pharma is not interested, academics are working on a test on pledge -- fledgling treatments. >> nih developmented their vaccine research center. a vaccine that works in monkeys. now is the time to find out if it works in humans. it's a matter of when, not if a full case of ebola makes it's way here. >>> in a story about an east bay elementary school robbed twice this summer. team san lorenzo to recoup the lost. the principal reports that members of the community have helped replace stolen gym equipment, the school has received $6,000 to replace supplies. thieves broke in july 31 and last week. the principal is installing tougher locks on doors. >>> twitter is making changes to give mourning families more rights on social media. the challenges involved in limiting what is what isn't appropriate to tweet. >>> the tarp over the wrigley field may be resolved. >>> after the break, i'm looking at temperature that will increase. how much warmer is it going to get in your neighborhood on thursday. hey can you fix this? you bet! that's our new interactive speaker wall. 'sup? thinks it

so, if you look at the large-cap pharmas, right?eir valuations improve dramatically from being, you know, sort of glorified bonds, if you will, to now, you know, having pes based on growth opportunities from their pipelines, they're still massively below the biotech sector. and the reason that pharma companies would do big deals with biotech is really two. one is, obviously, to improve their pipeline, but most importantly, they've got to accelerate earnings, and those deals would be just massively dilutive. >> when you look at the winners and losers in this, i think the only way to play if you're a retail investor, look at something like xbi. i like -- >> an etf. >> an etf. if i had a choice between investing in china or biotech, give that to my son and say in 20 years i'm going to come back and visit this, i think i like biotech because it's going to solve a lot of problems for the entire world, versus china. it's going to be an economic engine, but i love biotech, but it's like making bets. when you try and figure out whooz going

. >>> why smaller biotech companies are on the front lines of the fight against obesity, not big pharma. >>> as if being in a hospital isn't troublesome enough. some people may have had their personal data hacked while they were getting better. community health systems says it was the victim of a cyber attack that originated in china. and that the personal data of 4 1/2 million patients including names, birthdates, social security numbers was stolen during april and june. >> we have so many overweight americans, you think big pharmaceutical giants would be at the forefront of treating obesity. that's not the case. and there's good reasons why small biotech firms are the ones leading the fight against fat. >> it's a disease that affects one in three american adults. more than 78 million people. but using drugs to treat obesity has been an uphill battle. >> people have regarded obesity as the problem of the patient. very much that it's there responsibility for becoming obese. and it's their responsibility to become lean again. >> how is obesity defined? the cdc says it's a body mass index

the business model of the pharma companies is not hard to understand.is the same one used by hollywood. they find interesting projects and they bring them in-house and then polish them, they get them through sensors, the fda, and their marketing and advertising teams start to work to deliver it to the public. it is long and risky and expensive, which is why, like hollywood, drug companies choose to seek blockbusters. when you think about it targeted medicine, they are more like those little indie art films, not a big audience. if you are making a niche drug, the result is, it ends up being phenomenally expensive. it is hard to get the insurance companies to pay for it or for an individual to pay for it. the best medicines end up helping the fewest people. kind of ironic. i started thinking about this a lot, how could this trend he -- be reversed, how can we make a drug company that truly made faster, better, cheaper medicines and start to generate cancer drugs? you want to beat cancer, make better drugs. if i see everyone going one way, the whole indust

on this farm in fact the fish have caught several diseases so this a big pharma. pet leakiest amount is a researcher at the university of number were in belgium. he came to help this farmer to treat his sick pengo. do not have too many problem with. the z's his auto body oh yes to their body and there is also bleeding now leading in the finale have something yes blake did ok bleeding you know yes. i think the proper way and they also get a liver disease in the viva yes. this. is just a moment is going to discover that to treat the fish farmers use dangerous doses of drugs. that. oh crunch of chemical hey. pass this here you can see the antibiotics. in this local pharmacy there are hundreds of boxes of antibiotics of all kinds heavily used on the farms they cause a chain reaction. ok the problem and the problem is that there are always residues but were found in the environment and eventually the bacteria becomes resistant to these antibiotics is all to get. regularly administered to the fish these antibiotics heighten the diseases they're supposed to fight forcing

allergan continues to be one of the big pharma companies with growth.hey're putting out big numbers in 2015, 2016. i think it's just beginning for allergan. you can win two ways. >> david did mention on friday this letter to the judge, saying that a third of the investors of allergan asked for the special meeting trying to oust a majority of the board before the year's up. >> look, people who want money fast and want money slow. i think aller georgian's a situatiwhere products came in, trying to get higher prices. i believe in dave pyott. people don't want a longer term view, they want instant profits. i believe in pie out. >> you think the ten year's done coming down in yield? >> no, not if i see austerity in europe. i mean if the merkel forces continue to win, then you're going to want -- pay 2 1/8 for the ten year. the ideologyists are saying ten-year should not be here. it's fostering too much risk. i heard that from martin feldstein. but the problem with that is that why do i want the italian ten-year, spanish ten-year, when i can be in a stable gr

. >> by the standards of pharma deals that have been fairly conservative. hase it why for, novartis, made a large a deal as on of a four-way transaction. strengthened by the deal. would've seen pfizer trying to make a big move with astrazeneca roche successfully shire. has set out the real chess piece types of will. it could be their effort to get things going. >> matt campbell. thank you. let's stick with m&a. vivendi continues. telefonica italian is expected to raise stakes with an offer for the internet provider. here with an update is caroline hyde. we were talking about this on friday. bring us up to date. >> we were using analogies on friday talking about these latin lovers. trying to woo the heart of brazilian babe, gvt. we only knew that telefonica has been talking to her father and we knew they would be in discussions. -- do we have not gotten any diamond ring. there's already been a $6 billion prize. what are they coming for? pretty bling. stake tod offer a 20% vivendi, saying you can take some of me but also i will give you scan and in that game

some of the same big corporations that are also contributing to republicans -- wal-mart, pfizer, big pharma, comcast and others, friendly corporate lobbyists help run this. one of its board members is a lobbyist for the us chamber of commerce and they call themselves the new deal. >> that is exactly what's wrong and why people are sick of politics that you would think that the answer, that a democratic organization would think that the answer is for them to get corporate money as well. that's what happened in texas. the people didn't turn right wing. they quit voting because the democrats quit being democrats for exactly the reason that, of what cory booker is doing there. they went out and got the corporate money. and you take that check, you know, you're not going to be talking populist old democratic rallying the troops and going at the bastards and big shots and b.s.'ers. you're not going to be talking about good jobs at good wages, not just jobs. good, you know, jobs that have wages attached to them, living wages. you're not going to be talking about medicare for all, you know, not med

that would just be temporary a more work needs to be done in communities to stop gang culture andree pharma arts a london court now we continue our report looking at how often some people laugh time passes in the blink of an eye. on marriage and the financial world. cannot stop exit exams only take the credit not going to get it in life there are good and there are but. they all talk about language as well but i will only react to situations i have read reports like pushing the no i will leave the state park to comment on your latter point to say. the security of a car is on the job. no. thank you no more weasel. when you need a direct question are you prepared for a change when you have to. be ready for a. freedom of speech is little doubt the freedom to watch. i think. we're going to go digital the price is the only industry specifically mentioned in the constitution and. that's because a free and open process is critical to our democracy albus. in fact the single biggest threat facing our nation today is the corporate takeover of our government and across a semi-colon we've been hijacked

andrey pharma r.t. . while the islamic state is considered too violent even by al qaeda leaders but despite the atrocities the militants seem to be finding growing support in europe now in france a poll suggests fifteen percent of the population support islamic state and a third of those aged between eighteen and twenty four some of the islamic states popularity is being attributed to its p.r. campaign on the web on social media there have been many images posted of famous european monuments emblazoned with arabic slogans such as long live the islamic state for us or one luis gonzalez perez believes the rising radicalization is the result of european and american policy in the middle east. you know hearings by the islamic state that it aims to expand the borders of the caliphate to europe only to draw attention of the media and turn the organization into the world's largest terrorist group the jihadist groups in our country have always been closer to al qaeda is the internationalization of these their mix

artie's under pharma now assessing the role of russia in the first world war. pran ferdinand's murder in late she set off a chain of events that would lead to the great war within a matter of days the great powers of europe particularly had war on each other and on this day exactly a century ago or three hungary declared war on russia when it all started crags cheered and welcome the fighting little did they know of the horrors that lay ahead while the battle lines were drawn long before russia joined with britain and france forming the allied powers on one side and on the other side the central powers of austria-hungary in germany later joined by the ottoman empire garia while russia fielded five million men at the start almost as much as germany and austria hungary combined and war raged everywhere. and always warships delivered tons of rands with the explosion shaken expanse of the sea conflict filled the sky city for the first time in pilots of the first war planes were regarded as he writes the breakthrough for russia came in nine hundred sixteen russian a

andrey pharma r.t. . the islamic state was considered too violent even by al-qaeda but even these brutal killers have their achilles heel this time it seems it's in the form of female kurdish soldiers there on the track of the islamists looking to avenge the thousands of women captured and executed by the islamic state and for the jihadists the female fighters pose a very specific threat they believe that if you are killed by a woman there's no place in heaven for you this is a video of us some of the volunteers joining the all female units train with and fight alongside male fighters. well the threat of the islamic state is spreading far beyond europe and the middle east indonesian police have been put on alert the world's largest put its temple after a threat made by jihadists all the details on our website. plus thirty four sailors have been dismissed after a seven year long fraud scandal at the u.s. navy's nuclear power training site find out why on a website party dot com. russia's block on importing

medical systems and serve and solve all sorts of problems they have one of the most advanced bio pharma sectors of any country in the entire world to develop all sorts of very interesting and very groundbreaking and pathbreaking drugs so in and of itself it's sort of a ridiculous thing that usa aidid to come in there and teach them how to deal with hiv aids right and considering the failure of the cia vaccination polio program and pakistan i mean we're talking about a program that caused actually a rise in the perfect disease and also there's polio vaccination workers getting gunned down because they found out that they were working with the cia total devastation there why do you think this administration hasn't learned about kind of using serious health issues as a front for covert intelligence actually is detrimental well i think it's not that they haven't learned that they don't care i mean obviously it has a detrimental effect all n.g.o.s who are doing this sort of thing have said over and over again that it has a detrimental effect but when you key point when the key goal of your g

intercept pharma releasing positive data on an experimental liver drug.ial showing that the drug may have had a more benign effect on patients' cholesterol levels than first thought. and that's pretty interesting news. and that stock today, the stock up about 58%. when you break down that symbol, wapner, please, for halftime report? don't you think you might want to look at that? >> i think we'll talk about that. >> are you going to watch? >> you don't have to force every day -- >> you're welcome >> speech recognition software maker nuance communications posting earnings in line with estimates. revenue, though, missed the mark. in current quarter guidance, falls short of consensus. apple's siri feature is powered by nuance. people don't use siri nearly as much -- have you tried it? >> i think i've used it maybe once. >> you can use it for everything. call home, call -- >> do you use it? >> yeah, you can use it when you don't -- you should be using it at times when you're not. where you can just say, find a domino's or whatever it is. whatever number that

the white house and all the bio pharma companies involved are already coming under fire from both sides of this vaccine argument the makers of the map say they have depleted their entire stock of the drug which was just set to go into animal testing phase and they were about a year away from being ready to test on humans when this outbreak hit now on the one hand because dr brantley is doing so well almost immediately following his vaccination some are hailing this as a miracle drug or even a cure for ebola it's also believe though that seventy five year old spanish priest miguel harris who died over the weekend was given that drug so pressure is mounting on the makers of the map and the obama administration to facilitate faster production of the drug now the f.d.a. has not approved this medicine for wide public use and can in no way confirm that it can help patients so world health leaders are kind of mired in a catch twenty two. if they don't allow further use of the map the public will say they're allowing people to die unnecessarily on the other hand if they allow the use of the map

aviva is the salesforce for the pharma industry.he right way to think of your company for the shorthand? >> for the shorthand, the way to think about it is that we are delivering the industry clout. the industry specific software for companies. pfizer,anies are novartis, eli lilly. they're trying to improve and extend human lives. a very specific mission. toare helping them do that, help them develop drugs faster, bring them to market more effectively. transform trying to the industry. a specific industry. >> this demonstrates the notion of how the software industry works. i've covered this for a long time. 28% of all software sales, that is eager than the database market. much bigger than the operating system market. what has the trend been there? >> what is happening is that it has been the case but it is accelerating. isustry specific software big as the as -- market. with cloud software, you can tackle these industry-specific problems more effectively, you can use the use of that to generate data. it is accelerating the value of

. >> i think of viva as the salesforce as the pharma industry.is that the right way to think about your company? >> the way to think about it, we are delivering the industry clad for life sciences. our customers are people like pfizer, novartis, and we are delivering cloud solutions to help them with their critical problems. these companies are trying to extend human life. them do that by helping them with technology that helps them develop drugs faster and bring them to market more effectively. transform anto industry, a specific industry with clouds technology. study thata demonstrated this notion of how the software industry works. it really blew my mind about the specificity. industry specific software, 28% of all software sales. i'm amazed by that. that is bigger than the database market. the operatingan systems market. has this always been the case in what has been the trend in software? >> you know, what is happening, it is been the case, but accelerating. here is the point i tell people. industry-specific software is four times as big as

this is the return to the traditional company buying a big pharma.nd to see with the deals is much higher premiums. this was a premium of 38% for intermune from where it closed on friday. and lists said it was a little higher than they expected, but that could have been the result of a bidding war. there were potentially several parties interested here. and the drug for the pulmonary fibrosis, there's nothing on the market here, so it's a big opportunity. a analysts believe this could bring in a billion dollars. this affects 100,000 people in the u.s., this disease, so it's a big need. this is a return of big pharma buying the traditional business, so it has nothing to do with taxes. >> thank you very much. we appreciate it. >>> we just need to get you a look at what is taking place on the agenda in the united states. the big focus is new home sales data around 10:00 a.m. new york time. wall street is expected to gain 406,000 new homes since june. >>> the 2014 emmy awards held tonight in los angeles in the drama category, "breaking bad" is facing off

. >> aveva is the salesforce for the pharma industry. or something. the ceo and founder joins me. the right way to think of your company for the shorthand? >> for the shorthand, the way to think about it is that we are delivering the industry cloud for life sciences. the industry specific software for companies. our companies are pfizer, novartis, eli lilly. we are delivering cloud solutions to help them with their most critical problems. these companies are trying to improve and extend human lives. a very specific mission. we are helping them do that, to help them develop drugs faster, bring them to market more effectively. so, we are trying to transform the industry. a specific industry. >> i saw a study that demonstrated the notion of how the software industry works. i covered this for a long time, but it blew my mind, the specificity. industry-specific software is 20% of all software sales. i was amazed by that. bigger than the database market. massively. much bigger than the operating system market. has this always been the case? what has the trend been there? >> you know, wh

it happened at pharma-chem laboratories.. which produces ingredients which flavor foods. investigators say workers just started on a new recipe for eggnog when it ignited. authorities say half of the building may have to be torn down. the cause of the explosion is being investigated. a giant tortoise was spotted wondering around california. police say the reptile tried to make a run for it... but to no avail. it took two officers to lift the 150 pound reptile into a patrol car. the tortoise was then housed at l-a county's animal care and control center. but now he's back at home with his human family and his best pal... a bulldog. >> that story makes me feel good. stern enough miles in the '60s. highs will be in the '80s. this will probably be the warmest day. 65 right now. 68 along the lakefront. we have dew points that are relatively high. low to mid '60's. it may feel the steamy to start things off. we have a good combination to create some fog this morning. visibility is down to near zero. a few miles down near kankakee. thicker fog to the south and the west. otherwis